News & views
Thermo Fisher Scientific Completes Sale
Mar 28 2014
Thermo Fisher Scientific a world leader in serving science, has completed the sale of its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company (NYSE: GE), for $1.065 billion.
The businesses will become part of GE Healthcare’s Life Sciences division. The combined revenue of the three businesses was $250 million in 2013. Thermo Fisher committed to sell these businesses to address regulatory concerns related to its acquisition of Life Technologies Corporation, which was completed on February 3, 2014.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan